Announcing the launch of our nonprofit, the Colossal Foundation, which will deploy cutting edge technology to partners in the field so we can continue to save threatened and endangered species. #conservation #deextinction #endextinction #sciencenews
关于我们
The science of genetics. The business of discovery. Colossal is a breakthrough bioscience and genetic engineering company that builds radical new technologies to advance the field of genomics. Colossal creates disruptive technologies for extinct species restoration, critically endangered species protection and the repopulation of critical ecosystems that support the continuation of life on Earth. The company is the first to apply CRISPR technology for the purposes of species de-extinction, beginning with the woolly mammoth. Colossal is accepting humanity’s duty to restore Earth to a healthier state, while also solving for the future economies and biological necessities of the human condition through cutting-edge science and technologies.
- 网站
-
https://colossal.com/
Colossal Biosciences的外部链接
- 所属行业
- 生物技术研究
- 规模
- 51-200 人
- 类型
- 私人持股
- 创立
- 2021
Colossal Biosciences员工
-
Barry Stamos
3x Exited Founder | CEO @ Supernova ? | Mentor & Advisor | Keynote Speaker | Dad | Conscious Mode ?
-
John McKinley
Strategic advisor and investor to some great companies!
-
Ming Zhan
Principal Scientist, Genome Engineering, Colossal
-
Ben Lamm
Just a guy working to bring back mammoths (and other stuff)
动态
-
iPSC cells are special cells that can become any type of cell in the body and propagate endlessly. This breakthrough with elephant iPSCs doesn’t just help our de-extinction work—it opens doors to studying diseases, testing new medicines, creating synthetic embryos, and even helping endangered species through advanced cell therapies.
-
Special thanks to Springer Nature for partnering with us on the UK premiere of Hunt for the Oldest DNA and Magdalena Skipper for hosting an insightful Q&A with Beth Shapiro and Ben Lamm. ??
On 2 October Nature co-hosted the UK premiere of the Hunt for the Oldest DNA -– the epic story of efforts by Eske Willerslev and colleagues to sequence ancient DNA from sediments in Greenland. With our partners Colossal Biosciences we held a special film screening at the Science Museum in London with a drinks reception attended by journalists, scientists, and editors followed after the premiere by a fascinating panel discussion, featuring Colossal experts and the film’s director and chaired by Magdalena Skipper, about ancient DNA and efforts to bring back extinct species such as the woolly mammoth. The London Springer Nature office and staff were prominently featured in the film when Eske and co-authors visited to participate in a press briefing to share their discovery, published in Nature in 2022, with the global media. You can read the original paper here: https://lnkd.in/db89XtiC Nature Portfolio
-
-
Thank a huge colossal thank you to Peter Jackson and Fran Walsh for investing in our mission to end extinction ?? https://lnkd.in/gY93-_25 #startups #investors #innovation #sciencenews
-
Congrats to our partners Colossal Biosciences on creating their foundation to secure their commitment to helping conserve threatened species, like the Victorian Grassland Earless Dragon. We look forward to our continued work together.
Announcing the launch of our nonprofit, the Colossal Foundation, which will deploy cutting edge technology to partners in the field so we can continue to save threatened and endangered species. #conservation #deextinction #endextinction #sciencenews
-
Full story on Newsweek: "Colossal Is The Real Life Blockbuster of 'Jurassic Park' and 'Indiana Jones' With Celebs Like Tom Brady Behind It"
-
-
“We started The Colossal Foundation to ensure that we are delivering our technology solutions into the hands of those who can benefit the most.” – Colossal CEO and co-founder Ben Lamm Read the article from SYFY: https://lnkd.in/eyn3Teip
-
-
I'm delighted to share the announcement that Colossal Biosciences has now launched the Colossal Foundation. The Foundation is a non-profit arm of Colossal, and has kicked off with an initial $50 million of secured funding targeted at stopping the coming extinction crisis. As well as preserving and increasing populations of endangered and at-risk animals, Colossal is working to de-extinct Tasmanian apex predator and keystone species, the Thylacine ?? https://lnkd.in/g9DYuf-M https://lnkd.in/geAY8HCm Colossal Biosciences Ben Lamm Andrew Pask
-